U.S. markets open in 1 hour 56 minutes
  • S&P Futures

    4,261.00
    +5.00 (+0.12%)
     
  • Dow Futures

    34,186.00
    +104.00 (+0.31%)
     
  • Nasdaq Futures

    14,373.75
    +19.50 (+0.14%)
     
  • Russell 2000 Futures

    2,334.50
    +3.30 (+0.14%)
     
  • Crude Oil

    73.12
    -0.18 (-0.25%)
     
  • Gold

    1,783.70
    +7.00 (+0.39%)
     
  • Silver

    26.25
    +0.20 (+0.77%)
     
  • EUR/USD

    1.1952
    +0.0017 (+0.14%)
     
  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     
  • Vix

    16.02
    -0.30 (-1.84%)
     
  • GBP/USD

    1.3898
    -0.0023 (-0.17%)
     
  • USD/JPY

    110.7100
    -0.1250 (-0.11%)
     
  • BTC-USD

    33,508.00
    +15.82 (+0.05%)
     
  • CMC Crypto 200

    798.26
    +11.64 (+1.48%)
     
  • FTSE 100

    7,119.10
    +9.13 (+0.13%)
     
  • Nikkei 225

    29,066.18
    +190.95 (+0.66%)
     

European Union Announce Second Lawsuit Against AstraZeneca Over Delayed COVID-19 Vaccine Supply: Reuters

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • The European Union has reportedly launched a new lawsuit against AstraZeneca plc (NASDAQ: AZN) that could lead to financial sanctions for the company, which the E.U. alleges has breached a supply contract for COVID-19 vaccines.

  • The lawsuit is the E.U.'s second against AstraZeneca after the bloc took action at the end of April over delayed vaccine supplies.

  • AstraZeneca has said the E.U.'s first legal action is without merit, saying that it complied with the contract, Reuters reported.

  • E.U. lawyer Rafael Jafferali, speaking in a Belgian court, asked AstraZeneca to deliver a total of 120 million vaccine doses by the end of June.

  • The company had initially committed to delivering 300 million vaccine doses from December to the end of June but has delayed shipments, having delivered only 50 million.

  • AstraZeneca aims to ship 100 million shots by mid-year, which the company's lawyer Hakim Boularbah confirmed.

  • Boularbah said AstraZeneca was not obliged to deliver the entire volume of doses set in the contract because it only committed to making its "best reasonable efforts" to achieve it.

  • The company has cited production problems and export restrictions as reasons for its delayed supplies to the E.U.

  • The E.U. lawyer also asked AstraZeneca to share confidential documents, a request which AstraZeneca opposes.

  • Price Action: AZN shares are trading 0.74% lower at $53.98 during the market trading session on the last check Tuesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.